PCRX
Pacira BioSciences, Inc.
25.40$
+1.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.2% | 28.9% | 39.8% | 30.7% | 25.7% | 25.3% | 27.3% | 25.9% | 29.9% | 27.4% | 24.3% | 20.6% | |
| 60.8% | 71.1% | 60.2% | 69.3% | 74.3% | 74.7% | 72.7% | 74.1% | 70.1% | 72.6% | 75.7% | 79.4% | |
| 9.5% | 11.5% | 16.5% | 20.0% | 16.5% | 17.1% | 13.8% | 10.3% | 12.7% | 11.3% | 11.6% | 16.1% | |
| 21.1% | 24.6% | 22.9% | 23.3% | 20.8% | 16.9% | 17.4% | 16.3% | 16.4% | 17.2% | 17.4% | 19.6% | |
| 63.4% | 67.4% | 71.7% | 76.3% | 69.1% | 72.2% | 61.9% | 57.5% | 61.1% | 59.7% | 86.2% | 74.8% | |
| -2.6% | 3.8% | -11.6% | -8.7% | 4.7% | 2.5% | 10.8% | 16.6% | 9.0% | 13.0% | -10.5% | 4.6% | |
| 4.2% | 3.1% | 2.6% | 6.3% | 6.5% | 5.6% | 6.0% | 5.4% | 5.3% | 2.6% | 2.4% | 2.0% | |
| -6.9% | 0.9% | -13.7% | -14.8% | -0.1% | -2.6% | 4.7% | 10.4% | 2.0% | 9.1% | -9.0% | 2.3% | |
| 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.1% | -29.2% | 2.7% | -0.4% | 2.9% | 5.2% | 1.4% | |
| -6.9% | 0.7% | -13.7% | -14.9% | -0.1% | -2.6% | 33.9% | 7.8% | 2.4% | 6.2% | -14.2% | 1.0% | |
| 2.6% | 8.6% | -6.5% | -3.7% | 9.8% | 7.3% | 14.8% | 21.0% | 21.1% | 22.9% | 4.2% | 16.9% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.